Register Now

Sun Pharma names Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman

Ganorkar has been heading the India business of Sun Pharma since 2019 and will take over as MD effective September 1, 2025. Shares of Sun Pharmaceutical Industries Ltd ended at ₹1688.70, up by ₹1.70, or 0.10%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *